Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protease Inhibitors”

525 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 525 results

Large-scale testing (Phase 3)Study completedNCT00013520
What this trial is testing

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,125
Not applicableStudy completedNCT00034086
What this trial is testing

Study of Anti-HIV Therapy Intensification

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Testing effectiveness (Phase 2)Study completedNCT00589056
What this trial is testing

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 55
Large-scale testing (Phase 3)Active Not RecruitingNCT01983241
What this trial is testing

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

Who this might be right for
Pulmonary Emphysema in Alpha-1 PI Deficiency
Grifols Therapeutics LLC 345
Post-approval studies (Phase 4)Ended earlyNCT02531321
What this trial is testing

Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics

Who this might be right for
ContraceptionHIV
University of Southern California 17
Testing effectiveness (Phase 2)Study completedNCT00001085
What this trial is testing

141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Early research (Phase 1)Ended earlyNCT01086332
What this trial is testing

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Iowa 7
Post-approval studies (Phase 4)Study completedNCT00449436
What this trial is testing

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Who this might be right for
HIV Infections
GlaxoSmithKline 152
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Not applicableUnknownNCT02354209
What this trial is testing

Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy

Who this might be right for
HIV
St Stephens Aids Trust 50
Testing effectiveness (Phase 2)Study completedNCT00021463
What this trial is testing

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 342
Testing effectiveness (Phase 2)Study completedNCT00004578
What this trial is testing

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Who this might be right for
HIV Infections
Abbott 100
Large-scale testing (Phase 3)Study completedNCT00002397
What this trial is testing

Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Who this might be right for
HIV InfectionsAIDS-Associated Nephropathy
Hoffmann-La Roche 24
Early research (Phase 1)Study completedNCT01148004
What this trial is testing

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Who this might be right for
HIVFenofibrateProtease Inhibitors+2 more
National Institutes of Health Clinical Center (CC) 25
Early research (Phase 1)Study completedNCT00001108
What this trial is testing

The Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Not applicableStudy completedNCT02130687
What this trial is testing

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusHypertension
Vanderbilt University 106
Testing effectiveness (Phase 2)WithdrawnNCT01183455
What this trial is testing

A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00849160
What this trial is testing

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Who this might be right for
HIV-1 InfectionHIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 100
Testing effectiveness (Phase 2)Study completedNCT00001084
What this trial is testing

Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 500
Early research (Phase 1)Study completedNCT01046058
What this trial is testing

TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 23
Load More Results